Skip to content
LetsInvest
Compare

More Guides

NPS Swasthya: The Health-Linked NPS Variant, Explained Honestly

PFRDA's specific-purpose scheme (launched January 2026) pairs a retirement corpus with group super top-up health cover and medical withdrawals — what it does, what it does not, and who should use it.

By LetsInvest Research DeskUpdated 30 Oct 20263 min read

On this page (4 sections)

NPS Swasthya is PFRDA's attempt to answer a fair complaint: India's pension accounts ignore the health costs that actually derail retirements. Launched in January 2026 as a specific-purpose pension scheme under Regulation 4A of PFRDA's exit-and-withdrawal regulations, it pairs the standard NPS retirement corpus with two health features — access to group super top-up insurance and partial withdrawals earmarked for medical expenses. This page explains the mechanics and, more usefully, who should and should not use it.

What exactly is it?

Think of it as NPS with a medical relief valve. The account builds a retirement corpus exactly like Tier-I NPS does — market-linked, invested through pension funds — but adds: (1) healthcare withdrawals: once the corpus crosses the threshold (reported at ₹50,000), a subscriber can withdraw up to 25% of their own contribution for eligible healthcare expenses, including eligible out-patient costs; and (2) group super top-up health insurance funded through the scheme, which covers large hospitalisation bills above a deductible layer. The minimum contribution follows the non-government NPS rules — reported at ₹1,000 to start, with no maximum. The binding text is PFRDA's operational-guidelines circular; press coverage summarises it, and the circular governs.

What problem does it actually solve?

Two, partly. A dedicated medical corpus removes the temptation to raid retirement savings for a hospital bill — the withdrawal is already legal, earmarked and capped. And the group super top-up gives retirees and pre-retirees a large-bill layer that individual policies price expensively or refuse at older entry ages. What it does not do: replace a personal health policy. A super top-up pays only above a deductible; a ₹5 lakh hospitalisation under a ₹10 lakh deductible top-up is still your bill — which is why the base policy stays non-negotiable (see our insurance audit for the base-plus-top-up structure).

How does it compare to the alternatives?

Against an ordinary Tier-I NPS account: Swasthya trades a little flexibility discipline for medical access — the same 25%-of-own-contribution withdrawal idea, but with healthcare as the listed purpose and a lower corpus trigger. Against a personal health policy: it is not a competitor; the premium-funded, claims-administered insurance layer is different machinery from a corpus. Against a self-built medical fund: Swasthya's version is market-linked and tax-sheltered like NPS, but capped at 25% of contributions — a self-built fund has no cap and no market risk. The honest read: it is a complement layered on health insurance, not a substitute for either insurance or the emergency fund.

Swasthya against the realistic alternatives

The scheme is a complement layered on health insurance — not a substitute for insurance or the emergency fund. Each row's binding constraint is in the last column.

View the numbers as a table
Swasthya against the realistic alternatives — the numbers behind the figure
OptionWhat it isMedical accessBinding constraint
NPS SwasthyaNPS corpus + healthcare withdrawals + group super top-up25% of own contributions, healthcare purposes, after ₹50K corpusThe cap; top-up deductible
Personal health policyIndemnity insurance, premium-fundedClaims up to sum insuredWaiting periods; entry age; premium inflation
Tier-I NPS (ordinary)Retirement corpus onlyPartial withdrawals, narrow purposesLocked to 60 (Dec-2025 exit rules)
Self-built medical fundLiquid savings you controlUnlimited, any purposeNo tax shelter; no market growth; discipline required

Launch details as reported by Moneycontrol, Deccan Chronicle and Mint (Jan 2026), checked 29 October 2026; PFRDA's operational circular is the governing text.

Who should use it — and who should not?

  • Fit: existing NPS subscribers (particularly self-employed and private-sector savers) who want a ring-fenced medical sleeve inside the retirement architecture, already hold a personal base policy, and understand the 25% cap. Also genuinely interesting for retirees and near-retirees who cannot buy fresh retail health cover easily — the group top-up layer is the feature standard products don't offer.
  • Not fit: anyone without a base health policy — the top-up's deductible will eat you first. Anyone whose medical corpus would need to exceed the 25% cap. And anyone hoping this changes NPS's core rules: exit at 60, the annuitisation slice and the exit rules all continue as on the NPS 2026 changelog; Swasthya is a health add-on, not a new exit regime.

Educational content, not financial advice. The scheme exists under Regulation 4A of PFRDA's exit regulations with operational guidelines issued by PFRDA; launch details (₹1,000 minimum, ₹50,000 corpus threshold, 25% healthcare-withdrawal cap, super top-up cover) are as reported by Moneycontrol, Deccan Chronicle and Mint from the January 2026 launch and checked 29 October 2026 — the circular's own text governs where coverage differs. New-scheme operational details (insurer empanelment, claim processes) will evolve; verify before acting.

Sources

Reviewed 29 Oct 2026. Launch facts verified on 29 October 2026; PFRDA’s own pages and circular are the governing sources.

Key takeaways

  • The withdrawal is earmarked, capped and legal — a medical relief valve that stops hospital bills from raiding the retirement corpus.
  • The 25%-of-own-contribution cap is the constraint: a self-built medical fund has no cap; Swasthya has structure but a ceiling.
  • Exit at 60, annuitisation and the December-2025 exit rules all continue unchanged — Swasthya is a health add-on, not a new exit regime.
  • No base policy? The top-up's deductible eats you first. Buy the base policy before anything else.
  • The binding text is PFRDA's operational-guidelines circular — press coverage summarises it; verify the current circular before acting.
Affiliate disclosure: LetsInvest earns a commission if you open an account via links on this page — at no extra cost to you. Rankings are editorial and never sold. Read how we make money and our methodology.